T. Rowe Price Health Sciences Fund, Inc.
CIK: 0001002624
Equity
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ABBV ABBVIE INC Since 2026-07-07 | 00287Y109 | Equity (Common) |
2.84%
|
$309.56 | 1,423,341 |
| 2 | AGIO AGIOS PHARMACEUTICALS INC Since 2026-07-07 | 00847X104 | Equity (Common) |
0.02%
|
$2.38 | 70,221 |
| 3 | AKTS AKTIS ONCOLOGY INC Since 2026-07-07 | 01021M104 | Equity (Common) |
0.05%
|
$5.97 | 333,745 |
| 4 | ALHC ALIGNMENT HEALTHCARE INC Since 2026-07-07 | 01625V104 | Equity (Common) |
0.24%
|
$26.00 | 1,475,585 |
| 5 | ALLO ALLOGENE THERAPEUTICS INC Since 2026-07-07 | 019770106 | Equity (Common) |
0.09%
|
$9.35 | 3,830,998 |
| 6 | ALNY ALNYLAM PHARMACEUTICALS INC Since 2026-07-07 | 02043Q107 | Equity (Common) |
1.62%
|
$175.99 | 531,894 |
| 7 | ANRO ALTO NEUROSCIENCE INC Since 2026-07-07 | 02157Q109 | Equity (Common) |
0.06%
|
$6.03 | 268,280 |
| 8 | ALMS ALUMIS INC Since 2026-07-07 | 022307102 | Equity (Common) |
0.24%
|
$26.18 | 1,188,623 |
| 9 | AMGN AMGEN INC Since 2026-07-07 | 031162100 | Equity (Common) |
0.98%
|
$106.86 | 303,722 |
| 10 | ANNX ANNEXON INC Since 2026-07-07 | 03589W102 | Equity (Common) |
0.01%
|
$0.98 | 176,618 |
| 11 | APGE APOGEE THERAPEUTICS INC Since 2026-07-07 | 03770N101 | Equity (Common) |
0.43%
|
$46.72 | 555,098 |
| 12 | ARWR ARROWHEAD PHARMACEUTICALS INC Since 2026-07-07 | 04280A100 | Equity (Common) |
0.17%
|
$18.89 | 301,270 |
| 13 | AZN ASTRAZENECA PLC Since 2026-07-07 | — | Equity (Common) |
3.17%
|
$345.38 | 1,751,235 |
| 14 | RNA ATRIUM THERAPEUTICS INC Since 2026-07-07 | 04965N104 | Equity (Common) |
0.08%
|
$8.91 | 666,325 |
| 15 | AURA AURA BIOSCIENCES INC Since 2026-07-07 | 05153U107 | Equity (Common) |
0.01%
|
$1.48 | 221,135 |
| 16 | AXSM AXSOME THERAPEUTICS INC Since 2026-07-07 | 05464T104 | Equity (Common) |
0.25%
|
$27.70 | 163,910 |
| 17 | BEAM BEAM THERAPEUTICS INC Since 2026-07-07 | 07373V105 | Equity (Common) |
0.24%
|
$26.07 | 1,093,992 |
| 18 | BBNX BETA BIONICS INC Since 2026-07-07 | 08659B102 | Equity (Common) |
0.01%
|
$1.13 | 113,126 |
| 19 | BCAX BICARA THERAPEUTICS INC Since 2026-07-07 | 055477103 | Equity (Common) |
0.12%
|
$12.78 | 642,514 |
| 20 | BHVN BIOHAVEN LTD Since 2026-07-07 | — | Equity (Common) |
0.10%
|
$10.39 | 1,228,554 |
| 21 | BBOT BridgeBio Oncology Therapeutics Inc Since 2026-07-07 | 107924102 | Equity (Common) |
0.03%
|
$2.98 | 333,485 |
| 22 | BBIO BRIDGEBIO PHARMA INC Since 2026-07-07 | 10806X102 | Equity (Common) |
0.59%
|
$64.17 | 864,149 |
| 23 | BTSG BRIGHTSPRING HEALTH SERVICES Since 2026-07-07 | 10950A106 | Equity (Common) |
0.98%
|
$107.12 | 2,514,077 |
| 24 | CABA CABALETTA BIO INC Since 2026-07-07 | 12674W109 | Equity (Common) |
0.02%
|
$1.64 | 608,501 |
| 25 | CAH CARDINAL HEALTH INC Since 2026-07-07 | 14149Y108 | Equity (Common) |
0.68%
|
$73.58 | 348,232 |
| 26 | CAI CARIS LIFE SCIENCES INC Since 2026-07-07 | 142152107 | Equity (Common) |
0.31%
|
$34.15 | 1,909,867 |
| 27 | CELC CELCUITY INC Since 2026-07-07 | 15102K100 | Equity (Common) |
0.56%
|
$60.61 | 531,000 |
| 28 | CLDX CELLDEX THERAPEUTICS INC Since 2026-07-07 | 15117B202 | Equity (Common) |
0.12%
|
$13.40 | 422,316 |
| 29 | COR CENCORA INC Since 2026-07-07 | 03073E105 | Equity (Common) |
0.52%
|
$56.46 | 179,717 |
| 30 | CGON CG ONCOLOGY INC Since 2026-07-07 | 156944100 | Equity (Common) |
0.69%
|
$75.03 | 1,108,573 |
| 31 | CLYM Climb Bio Inc Since 2026-07-07 | 28658R106 | Equity (Common) |
0.09%
|
$10.06 | 1,468,417 |
| 32 | COGT COGENT BIOSCIENCES INC Since 2026-07-07 | 19240Q201 | Equity (Common) |
0.12%
|
$12.55 | 326,181 |
| 33 | CRVS CORVUS PHARMACEUTICALS INC Since 2026-07-07 | 221015100 | Equity (Common) |
0.10%
|
$10.61 | 725,099 |
| 34 | CBIO CRESCENT BIOPHARMA INC Since 2026-07-07 | — | Equity (Common) |
0.04%
|
$4.06 | 221,065 |
| 35 | CGEM Cullinan Therapeutics Inc Since 2026-07-07 | 230031106 | Equity (Common) |
0.09%
|
$9.76 | 686,764 |
| 36 | DNLI DENALI THERAPEUTICS INC Since 2026-07-07 | 24823R105 | Equity (Common) |
0.08%
|
$8.99 | 468,129 |
| 37 | DNTH DIANTHUS THERAPEUTICS INC Since 2026-07-07 | 252828108 | Equity (Common) |
0.37%
|
$40.51 | 482,750 |
| 38 | IRON DISC MEDICINE INC Since 2026-07-07 | 254604101 | Equity (Common) |
0.11%
|
$11.93 | 186,605 |
| 39 | EIKN EIKON THERAPEUTICS INC Since 2026-07-07 | 282564103 | Equity (Common) |
0.03%
|
$3.69 | 349,098 |
| 40 | ELV ELEVANCE HEALTH INC Since 2026-07-07 | 036752103 | Equity (Common) |
0.66%
|
$71.51 | 244,278 |
| 41 | ELVN ENLIVEN THERAPEUTICS INC Since 2026-07-07 | 29337E102 | Equity (Common) |
0.02%
|
$2.11 | 53,863 |
| 42 | TRDA ENTRADA THERAPEUTICS INC Since 2026-07-07 | 29384C108 | Equity (Common) |
0.04%
|
$4.16 | 329,233 |
| 43 | ERAS ERASCA INC Since 2026-07-07 | 29479A108 | Equity (Common) |
0.19%
|
$20.19 | 1,247,913 |
| 44 | EVMN EVOMMUNE INC Since 2026-07-07 | 30054Y107 | Equity (Common) |
0.05%
|
$5.66 | 246,092 |
| 45 | GENB GENERATE BIOMEDICINES INC Since 2026-07-07 | 370920100 | Equity (Common) |
0.03%
|
$3.32 | 265,641 |
| 46 | GILD GILEAD SCIENCES INC Since 2026-07-07 | 375558103 | Equity (Common) |
2.60%
|
$283.60 | 2,034,836 |
| 47 | DNA GINKGO BIOWORKS HOLDINGS INC Since 2026-07-07 | 37611X209 | Equity (Common) |
0.00%
|
$0.14 | 23,550 |
| 48 | GH GUARDANT HEALTH INC Since 2026-07-07 | 40131M109 | Equity (Common) |
0.90%
|
$97.54 | 1,055,988 |
| 49 | HCA HCA HEALTHCARE INC Since 2026-07-07 | 40412C101 | Equity (Common) |
0.90%
|
$97.59 | 206,215 |
| 50 | HIMS HIMS & HERS HEALTH INC Since 2026-07-07 | 433000106 | Equity (Common) |
0.02%
|
$2.03 | 97,648 |
| 51 | IDYA IDEAYA BIOSCIENCES INC Since 2026-07-07 | 45166A102 | Equity (Common) |
0.08%
|
$8.63 | 259,143 |
| 52 | IDXX IDEXX LABORATORIES INC Since 2026-07-07 | 45168D104 | Equity (Common) |
0.22%
|
$23.91 | 42,552 |
| 53 | IMMX IMMIX BIOPHARMA INC Since 2026-07-07 | 45258H106 | Equity (Common) |
0.03%
|
$2.97 | 326,401 |
| 54 | IMNM IMMUNOME INC Since 2026-07-07 | 45257U108 | Equity (Common) |
0.33%
|
$36.43 | 1,665,614 |
| 55 | IMVT IMMUNOVANT INC Since 2026-07-07 | 45258J102 | Equity (Common) |
0.02%
|
$2.02 | 81,427 |
| 56 | INSP INSPIRE MEDICAL SYSTEMS INC Since 2026-07-07 | 457730109 | Equity (Common) |
0.06%
|
$5.99 | 116,160 |
| 57 | ISRG INTUITIVE SURGICAL INC Since 2026-07-07 | 46120E602 | Equity (Common) |
3.65%
|
$397.94 | 863,221 |
| 58 | IONS IONIS PHARMACEUTICALS INC Since 2026-07-07 | 462222100 | Equity (Common) |
0.61%
|
$66.29 | 882,823 |
| 59 | IOVA IOVANCE BIOTHERAPEUTICS INC Since 2026-07-07 | 462260100 | Equity (Common) |
0.07%
|
$7.18 | 2,047,047 |
| 60 | IQV IQVIA HOLDINGS INC Since 2026-07-07 | 46266C105 | Equity (Common) |
0.32%
|
$35.40 | 207,553 |
| 61 | JANX JANUX THERAPEUTICS INC Since 2026-07-07 | 47103J105 | Equity (Common) |
0.00%
|
$0.31 | 22,599 |
| 62 | JNJ JOHNSON & JOHNSON Since 2026-07-07 | 478160104 | Equity (Common) |
2.44%
|
$266.04 | 1,088,355 |
| 63 | KMTS KESTRA MEDICAL TECHNOLOGIES Since 2026-07-07 | — | Equity (Common) |
0.14%
|
$14.84 | 744,410 |
| 64 | KOD KODIAK SCIENCES INC Since 2026-07-07 | 50015M109 | Equity (Common) |
0.32%
|
$35.13 | 921,511 |
| 65 | KRYS KRYSTAL BIOTECH INC Since 2026-07-07 | 501147102 | Equity (Common) |
0.65%
|
$70.64 | 273,451 |
| 66 | KYMR KYMERA THERAPEUTICS INC Since 2026-07-07 | 501575104 | Equity (Common) |
0.77%
|
$83.49 | 1,002,367 |
| 67 | KYTX KYVERNA THERAPEUTICS INC Since 2026-07-07 | 501976104 | Equity (Common) |
0.09%
|
$9.86 | 1,142,161 |
| 68 | LNTH LANTHEUS HOLDINGS INC Since 2026-07-07 | 516544103 | Equity (Common) |
0.09%
|
$9.27 | 122,170 |
| 69 | LENZ LENZ THERAPEUTICS INC Since 2026-07-07 | 52635N103 | Equity (Common) |
0.01%
|
$1.32 | 144,751 |
| 70 | MDGL MADRIGAL PHARMACEUTICALS INC Since 2026-07-07 | 558868105 | Equity (Common) |
0.36%
|
$39.12 | 74,723 |
| 71 | MBX MBX BIOSCIENCES INC Since 2026-07-07 | 55287L101 | Equity (Common) |
0.20%
|
$21.53 | 721,309 |
| 72 | MDWD MEDIWOUND LTD Since 2026-07-07 | — | Equity (Common) |
0.01%
|
$1.00 | 62,181 |
| 73 | MEDP MEDPACE HOLDINGS INC Since 2026-07-07 | 58506Q109 | Equity (Common) |
0.10%
|
$11.01 | 22,932 |
| 74 | MRK MERCK & CO. INC. Since 2026-07-07 | 58933Y105 | Equity (Common) |
3.44%
|
$374.87 | 3,116,392 |
| 75 | MIRM MIRUM PHARMACEUTICALS INC Since 2026-07-07 | 604749101 | Equity (Common) |
0.19%
|
$20.78 | 224,930 |
| 76 | MOH MOLINA HEALTHCARE INC Since 2026-07-07 | 60855R100 | Equity (Common) |
0.10%
|
$11.42 | 85,655 |
| 77 | MNPR MONOPAR THERAPEUTICS INC Since 2026-07-07 | 61023L207 | Equity (Common) |
0.02%
|
$1.89 | 34,428 |
| 78 | GLUE MONTE ROSA THERAPEUTICS INC Since 2026-07-07 | 61225M102 | Equity (Common) |
0.28%
|
$30.75 | 1,869,110 |
| 79 | MLTX MOONLAKE IMMUNOTHERAPEUTICS Since 2026-07-07 | 61559X104 | Equity (Common) |
0.15%
|
$16.53 | 887,029 |
| 80 | NTRA NATERA INC Since 2026-07-07 | 632307104 | Equity (Common) |
1.03%
|
$112.34 | 561,746 |
| 81 | NRIX NURIX THERAPEUTICS INC Since 2026-07-07 | 67080M103 | Equity (Common) |
0.17%
|
$18.83 | 1,215,025 |
| 82 | NUVB NUVATION BIO INC Since 2026-07-07 | 67080N101 | Equity (Common) |
0.01%
|
$0.80 | 186,516 |
| 83 | OCUL OCULAR THERAPEUTIX INC Since 2026-07-07 | 67576A100 | Equity (Common) |
0.11%
|
$12.20 | 1,439,766 |
| 84 | OLMA OLEMA PHARMACEUTICALS INC Since 2026-07-07 | 68062P106 | Equity (Common) |
0.09%
|
$9.68 | 649,181 |
| 85 | ORIC ORIC PHARMACEUTICALS INC Since 2026-07-07 | 68622P109 | Equity (Common) |
0.20%
|
$22.05 | 1,740,383 |
| 86 | ORKA ORUKA THERAPEUTICS INC Since 2026-07-07 | 687604108 | Equity (Common) |
0.21%
|
$23.35 | 476,018 |
| 87 | PVLA PALVELLA THERAPEUTICS INC Since 2026-07-07 | 697947109 | Equity (Common) |
0.18%
|
$19.09 | 153,120 |
| 88 | PTGX PROTAGONIST THERAPEUTICS INC Since 2026-07-07 | 74366E102 | Equity (Common) |
1.11%
|
$120.37 | 1,142,059 |
| 89 | RDNT RADNET INC Since 2026-07-07 | 750491102 | Equity (Common) |
0.01%
|
$1.01 | 18,038 |
| 90 | RAPP RAPPORT THERAPEUTICS INC Since 2026-07-07 | 75383L102 | Equity (Common) |
0.17%
|
$18.81 | 601,105 |
| 91 | REGN REGENERON PHARMACEUTICALS Since 2026-07-07 | 75886F107 | Equity (Common) |
2.65%
|
$288.37 | 373,226 |
| 92 | RLAY RELAY THERAPEUTICS INC Since 2026-07-07 | 75943R102 | Equity (Common) |
0.12%
|
$12.94 | 1,299,962 |
| 93 | REPL REPLIMUNE GROUP INC Since 2026-07-07 | 76029N106 | Equity (Common) |
0.10%
|
$10.92 | 1,427,764 |
| 94 | RVMD REVOLUTION MEDICINES INC Since 2026-07-07 | 76155X100 | Equity (Common) |
1.36%
|
$147.79 | 1,519,722 |
| 95 | RVTY REVVITY INC Since 2026-07-07 | 714046109 | Equity (Common) |
0.22%
|
$24.03 | 274,277 |
| 96 | RYTM RHYTHM PHARMACEUTICALS INC Since 2026-07-07 | 76243J105 | Equity (Common) |
0.19%
|
$21.02 | 241,658 |
| 97 | RCKT ROCKET PHARMACEUTICALS INC Since 2026-07-07 | 77313F106 | Equity (Common) |
0.02%
|
$1.66 | 464,628 |
| 98 | ROIV ROIVANT SCIENCES LTD Since 2026-07-07 | — | Equity (Common) |
1.13%
|
$123.20 | 4,447,673 |
| 99 | STTK SHATTUCK LABS INC Since 2026-07-07 | 82024L103 | Equity (Common) |
0.08%
|
$8.79 | 1,366,288 |
| 100 | SION SIONNA THERAPEUTICS INC Since 2026-07-07 | 829401108 | Equity (Common) |
0.20%
|
$21.95 | 547,443 |
| 101 | SGP SPYGLASS PHARMA INC Since 2026-07-07 | 85220G109 | Equity (Common) |
0.07%
|
$7.53 | 290,792 |
| 102 | SYRE Spyre Therapeutics Inc Since 2026-07-07 | 00773J202 | Equity (Common) |
0.40%
|
$43.08 | 854,145 |
| 103 | STOK STOKE THERAPEUTICS INC Since 2026-07-07 | 86150R107 | Equity (Common) |
0.14%
|
$14.72 | 452,134 |
| 104 | SMMT SUMMIT THERAPEUTICS INC Since 2026-07-07 | 86627T108 | Equity (Common) |
1.04%
|
$112.78 | 5,948,323 |
| 105 | TNGX TANGO THERAPEUTICS INC Since 2026-07-07 | 87583X109 | Equity (Common) |
0.12%
|
$13.36 | 638,486 |
| 106 | TARS TARSUS PHARMACEUTICALS INC Since 2026-07-07 | 87650L103 | Equity (Common) |
0.11%
|
$12.34 | 175,856 |
| 107 | TECX TECTONIC THERAPEUTIC INC Since 2026-07-07 | 878972108 | Equity (Common) |
0.03%
|
$3.78 | 122,254 |
| 108 | TENX TENAX THERAPEUTICS INC Since 2026-07-07 | 88032L605 | Equity (Common) |
0.36%
|
$39.67 | 2,481,066 |
| 109 | TERN TERNS PHARMACEUTICALS INC Since 2026-07-07 | 880881107 | Equity (Common) |
0.27%
|
$29.37 | 557,042 |
| 110 | TMO THERMO FISHER SCIENTIFIC INC Since 2026-07-07 | 883556102 | Equity (Common) |
4.07%
|
$442.86 | 900,979 |
| 111 | TYRA TYRA BIOSCIENCES INC Since 2026-07-07 | 90240B106 | Equity (Common) |
0.11%
|
$11.76 | 307,082 |
| 112 | PCVX VAXCYTE INC Since 2026-07-07 | 92243G108 | Equity (Common) |
0.17%
|
$18.28 | 314,645 |
| 113 | VERA VERA THERAPEUTICS INC Since 2026-07-07 | 92337R101 | Equity (Common) |
0.46%
|
$49.72 | 1,235,806 |
| 114 | VTRS VIATRIS INC Since 2026-07-07 | 92556V106 | Equity (Common) |
0.11%
|
$12.53 | 927,240 |
| 115 | VRDN VIRIDIAN THERAPEUTICS INC Since 2026-07-07 | 92790C104 | Equity (Common) |
0.06%
|
$6.73 | 343,846 |
| 116 | WVE WAVE LIFE SCIENCES LTD Since 2026-07-07 | — | Equity (Common) |
0.14%
|
$15.28 | 2,107,233 |
| 117 | WST WEST PHARMACEUTICAL SERVICES Since 2026-07-07 | 955306105 | Equity (Common) |
0.22%
|
$24.47 | 97,625 |
| 118 | XNCR XENCOR INC Since 2026-07-07 | 98401F105 | Equity (Common) |
0.04%
|
$4.57 | 378,576 |
Frequently Asked Questions — T. Rowe Price Health Sciences Fund, Inc.
What type of mutual fund is T. Rowe Price Health Sciences Fund, Inc.?
T. Rowe Price Health Sciences Fund, Inc. is a SEC-registered Equity fund, with $10.9B in assets under management.
Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate.
As of its latest SEC N-PORT filing, T. Rowe Price Health Sciences Fund, Inc. holds 118 portfolio positions, all detailed in the holdings table on this page.
What are T. Rowe Price Health Sciences Fund, Inc.'s assets under management (AUM)?
T. Rowe Price Health Sciences Fund, Inc. has $10.9B in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting.
AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale.
AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are T. Rowe Price Health Sciences Fund, Inc.'s top holdings?
According to T. Rowe Price Health Sciences Fund, Inc.'s most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include
ABBVIE INC,
AGIOS PHARMACEUTICALS INC,
AKTIS ONCOLOGY INC
, among others.
The complete list of all 118 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above.
Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is T. Rowe Price Health Sciences Fund, Inc.'s expense ratio?
Expense ratio data for T. Rowe Price Health Sciences Fund, Inc. is not currently available in StockSifting's database.
The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors.
For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find T. Rowe Price Health Sciences Fund, Inc.'s SEC filings?
T. Rowe Price Health Sciences Fund, Inc. is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001002624.
You can access all of T. Rowe Price Health Sciences Fund, Inc.'s SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on
SEC EDGAR (CIK: 0001002624).
N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is T. Rowe Price Health Sciences Fund, Inc.'s holdings data on StockSifting?
Holdings data for T. Rowe Price Health Sciences Fund, Inc. on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing.
Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions.
The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released.
For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.